VISTAGEN THERAPEUTICS, INC. Proceeds from Sale of Securities, Operating Activities
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Proceeds from Sale of Securities, Operating Activities of $278.00 thousand for the 9-month period ending 2016-12-31, per its 10-Q filed 2017-02-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities · last filed 2017-02-13
- VISTAGEN THERAPEUTICS, INC. proceeds from sale of securities, operating activities for the quarter ending 2016-12-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. proceeds from sale of securities, operating activities for the quarter ending 2016-09-30 was $0.00.
- VISTAGEN THERAPEUTICS, INC. proceeds from sale of securities, operating activities for the quarter ending 2016-06-30 was $278.00K.
| Period end | Proceeds from Sale of Securities, Operating Activities 3 month | Proceeds from Sale of Securities, Operating Activities 6 month | Proceeds from Sale of Securities, Operating Activities 9 month |
|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-13 | $0.00 derived: sum of 2 quarters · filed 2017-02-13 | $278.00K 10-Q · filed 2017-02-13 |
| 2016-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | $278.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $278.00K 10-Q · filed 2016-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |